By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Immune Design Corporation 

1102 Columbia Street
Suite 104
Seattle  Washington  98104  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
Seattle's Immune Design Corporation (IMDZ) Files For $60 Million IPO 6/26/2014 4:00:44 PM
Immune Design Corporation Announces Treatment Of First Patient In Phase 1 Clinical Trial Of LV305 Immuno-Oncology Agent 6/5/2014 8:38:55 AM
Immune Design Corporation's GLAAS™ Discovery Platform Used In MEDI7510 Phase 1 Trial For Respiratory Syncytial Virus 5/27/2014 9:29:32 AM
Immune Design Corporation Appoints Franklin M. Berger To Board Of Directors 3/18/2014 6:34:05 AM
Immune Design Corporation Announces Treatment Of First Patient In Phase 1 Clinical Trial Of ID-G305 Cancer Immunotherapy Agent 2/27/2014 9:25:31 AM
Immune Design Corporation To Present At Upcoming Investor Conferences In February 2/3/2014 8:57:38 AM
Immune Design Corporation Announces Treatment Of First Patient In Phase 1 Clinical Trial Of ID-G100, An Investigational Immuno-Oncology Agent 1/27/2014 9:55:18 AM
Immune Design Corporation Lands $49 Million Series C; New Investors Include Drug Giant Sanofi (France) (SAN.PA) and Investment Firm SGBV 10/30/2013 6:17:28 AM
Immune Design Corporation Appoints Frank J. Hsu, M.D., Vice President, Head of Oncology 10/24/2013 9:41:04 AM
Immune Design Corporation Appoints Jan Henrik ter Meulen, M.D., Chief Scientific Officer 10/1/2013 9:39:24 AM
123
//-->